Rho-kinase (ROK) promotes CD44v3,8-10-ankyrin interaction and tumor cell migration in metastatic breast cancer cells

Cell Motility and the Cytoskeleton

Volumn 43, Issue 4, 1999, Pages 269-287

  Bourguignon, Lilly Y W ^a   Zhu, Hongbo ^a   Shao, Lijun ^a   Zhu, Dan ^a   Chen, You Wei ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Ankyrin; Breast tumor; CD44v3; Rho kinase (ROK)

Indexed keywords

ANKYRIN; BOTULINUM TOXIN; CD44V ANTIGEN; COMPLEMENTARY DNA; CYTOCHALASIN D; CYTOSKELETON PROTEIN; GUANOSINE TRIPHOSPHATASE; PROTEIN KINASE; RHO FACTOR;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANKYRINS; ANTIGENS, CD44; BREAST NEOPLASMS; CELL MOVEMENT; CYTOSKELETON; FEMALE; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; RABBITS; RECOMBINANT FUSION PROTEINS; RHOA GTP-BINDING PROTEIN; TUMOR CELLS, CULTURED;

EID: 0032812619     PISSN: 08861544     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5     Document Type: Article

References (75)

1. Aktories K, Weller U, Chhatwal GS. 1987. Botulinum ADP-ribosyltransferase C3 but not botulinum neurotoxins C1 and D ADP-ribosylates low molecular mass GTP-binding proteins. FEBS Lett 212:109-113.
2. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. 1996. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271:20246-20249.
3. Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K. 1997. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275:1308-1311.
4. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller. M. 1992. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682-685.
5. Bennet V. 1992. Ankyrins: adaptors between diverse plasmamembrane proteins and cytoplasm. J Biol Chem 267:8703-8706.
6. Bennet K, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A. 1995. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687-698.
7. Bourguignon LYW. 1996. Interactions between the membranecyloskeleton and CD44 during lymphocyte signal transduction and cell adhesion. Curr Topics Membr 43:293-312.
8. 2+ release. J Biol Chem 270:7257-7260.
9. Bourguignon LYW, Walker G, Suchard S, Balazovich K. 1986. A lymphoma plasma membrane-associated protein with ankyrin-like properties. J Cell Biol 102:2115-2124.
10. Bourguignon LYW, Kalomiris E, Lokeshwar VB. 1991. Acylation of the lymphoma transmembrane glycoprotein, GP85 may be required for GP85-ankyrin interaction. J Biol Chem 266;11761-11765.
11. Bourguignon LYW, Lokeshwar B, He J, Chen X, Bourguignon GJ. 1992. A CD44-like endothelial cell transmembrane glycoprotein GP116) interacts with extracellular matrix and ankyrin. Mol Cell Biol 12:4464-4471.
12. Bourguignon LYW, Lokeshwar VB, Chen X, Kerrick WG. 1993a. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunol 151:6634-6644.
13. 2+ from storage vesicles in mouse T-lymphoma cells. J Biol Chem 268:7290-7297.
14. 2+ release in T-lymphoma cells. J Biol Chem 270:17917-17922.
15. Bourguignon LYW, Iida N, Welsh CF, Zhu D, Krongrad A, Pasquale D. 1995b. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis. J Neuro-Oncol 26:201-208.
16. HER2, promotes human ovarian tumor cell activation. J Biol Chem 272:27913-27918.
17. Bourguignon LYW, Zhu H, Zhu D. 1998a. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Frontiers Biosci 3:637-649.
18. (3.8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 176:206-215.
19. Cheung ATW, Young LJT, Chen PCY, Chao CY, Ndoye A, Barry PA, Muller WJ, Cardiff RD. 1997. Microcirculation and Metastasis in a new mammary tumor model system. Int J Oncol 11:69-77.
20. Chu G, Hayakawa H, Berg P. 1987. Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acid Res 15:1311-1326.
21. Droll A, Dougherty ST, Chiu RK, Dirks JF, McBride WH, Cooper DL, Dougherty GJ. 1995. Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem 270:11567-11573.
22. Dvorak HF, Brown LF, Detmar M, Dvorak AM. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039.
23. Folkman J. 1985. Tumor angiogenesis. Adv Cancer Res 43:175-203.
24. Green S J, Tarone G, Underbill CB. 1988. Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor. Exp Cell Res 178:224-232.
25. Gunthert U, Hoffman M, Rudy W, Reber S, Zoller M, Haußmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24.
26. Guy CT, Cardiff RD, Muller WJ. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12:954-961.
27. Hall A. 1998. G proteins and small GTPases: distant relatives keep in touch. Science 279:509-514.
28. Haynes BF, Telen MJ, Hale LP, Denning SM. 1989. CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10:423-428.
29. Herrlich P, Zoller M, Pals ST, Ponta H. 1993. CD44 splice variants: metastases meet lymphocytes. Immunol Today 14:395-399.
30. Hirao M, Sato N, Kondo T, Yonemura S, Monden M, Sasaki T, Takai Y, Tsukita S, Tsukita S. 1996. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and rho-dependent signaling pathway. J Cell Biol 135:36-51.
31. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, Gunthert U. 1991. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292-5297.
32. Iida N, Bourguignon LYW. 1995. New CD44 splice variants associated with human breast cancer. J Cell Physiol 162:127-133.
33. Iida N, Bourguignon LYW. 1997. Coexpression of CD44 variant (v10/ex14) and CD44s in human mammary epithelial cells promotes tumorigenesis. J Cell Physiol 171:152-160.
34. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N. 1995. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673-685.
35. Jiang W G, Puntis MCA, Hallett MB. 1994. Inhibition of neutrophil respiratory burst and cytokine priming by gamma-linolenic acid. Br J Surg 81:1576-1590.
36. Kabcenell AK, Goud B, Northup JK, Novick PJ. 1990. Binding and hydrolysis of guanine nucleotides by Sec4p, a yeast protein involved in the regulation of vesicular traffic. J Biol Chem 265:9366-9372.
37. Kalomiris EL, Bourguignon LYW. 1988. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol 106:319-327.
38. Kalomiris E L, Bourguignon LYW. 1989. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85 and may function in GP85-ankyrin binding. J Biol Chem 264:8113-8119.
39. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. 1995. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345:615-619.
40. Kimura N, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, J Feng, Nakano T, Okawa K, Iwamatsu K, Kaibuchi K. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-248.
41. Kohli J. 1987. Genetic nomenclature and gene list of the fission yeast Schizosaccharomyces pombe. Curr Genet 11:575-589.
42. Kordeli E, Lambert S, Bennet V. 1995. Ankyrin G: a new ankyrin gene with neural-specific isoforms localized to the axonal initial segment and node of Ranvier. J Biol Chem 270:2352-2359.
43. Lauffenburger DA, Horwitz AF. 1996.. Cell migration: a physically integrated molecular process. Cell 84:359-369.
44. Lesley J, Trotter J, Hyman R. 1985, The Pgp-1 antigen is expressed on early fetal thymocytes. Immunogenetics 22:149-157.
45. Lesley J, Hyman R, Kincade P. 1993. CD44 and its interaction with extracellular matrix, Adv Immunol 54:271-235.
46. Letarte M, Iturbe S, Quackenbush EJ. 1985. A glycoprotein of molecular weight 85,000 on human cells of B-lineage: detection with a family of monoclonal antibodies. Mol Immunol 22:113-124.
47. Leung T, Chen XQ, Manser E, Lim L. 1996. The p 160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 16:5313-5327.
48. Lokeshwar VB, Bourguignon LYW. 1991. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J Biol Chem 266:17983-17989.
49. Lokeshwar VB, Bourguignon LYW. 1992. The lymphoma transmembrane glycoprotein CD44 GP85) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction. J Biol Chem 267:22073-22078.
50. Lokeshwar VB, Fregien N, Bourguignon LYW. 1994. Ankyrin binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol 126: 1099-1109.
51. Lokeshwar VB, Iida N, Bourguignon LYW. 1996. The cell adhesion molecule, GP116, is a new CD44 variant (ex 14/v 10) involved in hyaluronic acid binding and endothelial cell proliferation. J Biol Chem 271:23853-23864.
52. Lux SE, John KM, Bennett V. 1990. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell cycle control proteins. Nature 344:36-43.
53. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. 1996. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 15:2208-2216.
54. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S,Tsukita S. 1998. Rho-Kinase phosphorylates COOH-terminal threonines of Ezrin/Radixin/Moesin (ERM) proteins and regulatres their head-to-tail association. J Cell Biol 140:647-657.
55. Merzak A, Koochekpour S, Pilkington GJ. 1994. CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54:3988-3992.
56. Narumiya S. 1996. The small GTPase Rho: cellular functions and signal transduction. J Biochem 120:215-228.
57. Ohashi Y, Narumiya S. 1987. ADP-ribosylation of a Mr 21,000 membrane protein by type D botulinum toxin. J Biol Chem 262:1430-1433.
58. O'Neil L A J, Bird TA, Gearing AJH, Saklatvala J. 1990. Interleukin-1 signal transduction. Increased GTP binding and hydrolysis in membranes of a murine thymoma line (EL4). J Biol Chem 265:3146-3152.
59. Otto E, kunimoto M, McLaughlin T, Bennett V. 1991. Isolation and characterization of cDNA encoding human brain ankyrins reveal a family of alternatively spliced genes. J Cell Biol 114:241-253.
60. Peters L L, Lux SE. 1993. Ankyrins: structure and function in normal cells and hereditary spherocytes. Semin Hematol 30:85-118.
61. Peters LL, John KM, Lu FM, Eicher EM, Higgins A, Yialamas M, Turtzo L C, Otsuka AJ, Lux SE. 1995) : Ank3 (epithelial ankyrin), a widely distributed new member of the ankyrin gene family and the major ankyrin in kidney, is expressed in alternatively spliced forms, including forms that lack the repeat domain. J Cell Biol 130:313-330.
62. Rooney P, Kumar S, Wang M. 1995. The role of hyaluronan in tumour neovascularization. Int J Cancer 60:632-636.
63. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. 1992. Genomic structure of DNA coding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160-12164.
64. Sinn HP, Heider KH, Skroch-Angel P, von Minckwitz G, Kaufmann M, Herrlich P, and Ponta H. 1995. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Breast Cancer Res Treat 36:307-313.
65. Smith PR, Saccomani GM, Joe EH, Angelides KJ, Benos DJ. 1991. Amiloride-sensitive sodium channel is linked to the cytoskeleton in renal epithelial cells. Proc Natl Acad Sci USA 88:6971-6975.
66. Stamenkovic I, Amiot M, Pesando JM, Seed B. 1991. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343-347.
67. Takahashi K, Sasaki T, Mammoto A, Takaishi K, Kameyama T, Tsukita S, Tsukita S, Takai Y. 1997. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J Biol Chem 272:23371-23375.
68. Tsukita S, Oishi K, Sato N, Sagara I, Kawai A, Tsukita S. 1994. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin based cytoskeletons. J Cell Biol 126:391-401.
69. Turley EA, Austen L, Vandeligt K, Clary C. 1991. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol 112:1041-1047.
70. Welsh CF, Zhu D, Bourguignon LYW. 1995. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells. J Cell Physiol 164:605-612.
71. West D C, Kumar S. 1989. The effects of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 183:179-196.
72. ZhangL, Underhill CB, Chen LP. 1995. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 55:428-433.
73. Zhang Z, Devarajan P, Dorfman AL, Morrow JS. 1998. Structure of the ankyrin-binding domain of alpha-Na,K-ATPase. J Biol Chem 273:18681-18684.
74. neu-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion. Oncogene 12:2309-2314.
75. Zhu D, Bourguignon LYW. 1998. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation. Cell Motil Cytoskeleton 39:209-222.